Company Filing History:
Years Active: 2002-2013
Title: Fred Vinick: Innovator in TNF-α Signaling Modulation
Introduction
Fred Vinick is a notable inventor based in Lexington, MA (US). He has made significant contributions to the field of biomedical research, particularly in the modulation of TNF-α signaling. With a total of 4 patents to his name, Vinick's work has the potential to impact the treatment of various TNF-α mediated conditions.
Latest Patents
Vinick's latest patents focus on compounds that act as modulators of TNF-α signaling. These inventions provide methods for treating patients suffering from conditions mediated by TNF-α. The compounds can be represented by specific structural formulas, showcasing the innovative nature of his research.
Career Highlights
Throughout his career, Fred Vinick has been associated with Genzyme Corporation, where he has contributed to groundbreaking research and development. His work has been instrumental in advancing therapeutic options for patients with inflammatory conditions.
Collaborations
Vinick has collaborated with notable colleagues, including Bradford Hirth and Scott F Sneddon. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to significant advancements in their field.
Conclusion
Fred Vinick's contributions to the field of TNF-α signaling modulation exemplify the impact of dedicated inventors in biomedical research. His patents and collaborations continue to pave the way for new treatment options, highlighting the importance of innovation in healthcare.